Search
Descriptor English: Bortezomib
Descriptor Spanish: Bortezomib
Descriptor bortezomib
Scope note: Un derivado de las pirazinas y de los ácidos borónicos que actúa como INHIBIDOR DE PROTEASOMA reversible. Se utiliza como un ANTINEOPLÁSICO en el tratamiento del MIELOMA MÚLTIPLE y LINFOMA DE CÉLULAS DEL MANTO.
Descriptor Portuguese: Bortezomib
Descriptor French: Bortézomib
Entry term(s): LDP-341
LDP341
PS-341
PS341
Tree number(s): D01.029.260.110.500
D01.132.285.500
D02.203.200.500
D03.383.679.450
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000069286
Scope note: A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Antineoplastic Agents
Registry Number: 69G8BD63PP
DeCS ID: 55856
Unique ID: D000069286
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2016/05/27
Bortézomib - Preferred
Concept UI M0350110
Preferred term Bortézomib
LDP-341 - Narrower
Concept UI M0560884
Preferred term LDP-341
Entry term(s) LDP341
PS-341 - Narrower
Concept UI M0446631
Preferred term PS-341
Entry term(s) PS341



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey